Branch Retinal Artery Occlusion (BRAO) Medication

Updated: Feb 15, 2023
  • Author: Rishabh C Date, MD; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print

Medication Summary

To prevent stroke, most patients with branch retinal artery occlusion (BRAO) are placed on some form of antiplatelet therapy, such as aspirin, clopidogrel (Plavix), dipyridamole (Aggrenox), and ticlopidine (Ticlid).

Warfarin (Coumadin) is a blood thinner that prevents the blood from clotting. This medication often is used in patients with atrial fibrillation to decrease their risk for stroke.